-
AI-enhanced precision: boosting pathologist confidence in HER2 ultra-low diagnosis through intelligent re-screenin
Author: Wang, Xin-ping; Han, Ying; Yao, Min; Gao, Hong-Wen; Sun, Ping-Li
Journal: BREAST CANCER RESEARCH. 2026; Vol. 28, Issue 1, pp. -. DOI: 10.1186/s13058-026-02261-4
-
TLScope: a deep learning framework for quantifying tertiary lymphoid structures from H&E images reveals prognostic heterogeneity across breast cancer subtype
Author: Wang, Ruyuan; Liu, Sunyan; Zhao, Yuxi; Su, Yuhang; Peng, Qiyue; Zhu, Linsha; Zheng, Yiqiu; Xin, Ying; Li, Jiasu; Du, Yaying; Li, Ke; Li, Xingrui
Journal: BREAST CANCER RESEARCH. 2026; Vol. 28, Issue 1, pp. -. DOI: 10.1186/s13058-026-02241-8
-
CD19+Ki67+B cells regulated by NAMPT as key modulators in triple-negative breast cancer with brain metastasi
Author: Zhou, Qiyi; Zhu, Zhimin; Zhao, Yuxin; Jing, Di; Zhang, Liyuan
Journal: BREAST CANCER RESEARCH. 2026; Vol. 28, Issue 1, pp. -. DOI: 10.1186/s13058-026-02251-6
-
Chidamide combined with fulvestrant in the treatment of HR-positive, HER2-negative advanced breast cancer after failure of previous endocrine therapy: a single-arm, single-center, phase 2 stud
Author: Zou, La; Tang, Xianjun; Deng, Pan; Liu, Yijing; Yang, Ti; Tan, Xin; Yang, Lu; Li, Wei; Zeng, Xiaohua
Journal: BREAST CANCER RESEARCH. 2026; Vol. 28, Issue 1, pp. -. DOI: 10.1186/s13058-026-02254-3
-
FBR-NDs: a ferroptosis-inducing nanocomplex for targeted breast cancer therapy via immune modulation and redox-responsive drug deliver
Author: Chen, Jinjin; Ma, Liang; Yin, Ming; Sun, Jian; Sun, Yunhao
Journal: BREAST CANCER RESEARCH. 2026; Vol. 28, Issue 1, pp. -. DOI: 10.1186/s13058-026-02247-2
-
Mechanism of IL-4 mediated RPL19 promoting malignant progression in HER2 positive breast cance
Author: Zhang, Nana; Zhang, Jian; Shao, Junchao; Huang, Zhenfeng; Zhang, Jinxing; Wang, Hao; Lv, Liangshuang; Shen, Zibo; Zhang, Peng; Liu, Bing; Zhang, Guoqiang; Shan, Ming
Journal: BREAST CANCER RESEARCH. 2026; Vol. 28, Issue 1, pp. -. DOI: 10.1186/s13058-026-02240-9
-
Vascular abnormalization confers tumor resistance to antiangiogenic therapy via downregulating angiostatic factor
Author: Mao, Xunyuan; Cao, Xiangyu; Qian, Long; Gao, Meng; Zhang, Naidong; Huang, Mengmeng; Fan, Peng; Qi, Ziwei; Liu, Tingkun; Zhang, Hongjie; Huang, Yuhui
Journal: BREAST CANCER RESEARCH. 2026; Vol. 28, Issue 1, pp. -. DOI: 10.1186/s13058-026-02229-4
-
O-GlcNAcylation regulates the DNA damage repair function of MND1 in breast cance
Author: Zhai, Zhen; Wu, Jinpeng; Wei, Yumeng; Song, Ping; Wang, Meng; Lin, Shuai; Ma, Xiaobin; Lu, Yurong; Yang, Pengbo; Tan, Zengqi; Guan, Feng; Li, Xiang; Kang, Huafeng
Journal: BREAST CANCER RESEARCH. 2026; Vol. 28, Issue 1, pp. -. DOI: 10.1186/s13058-026-02233-8
